Novo Nordisk and AI-driven protein design company Gensaic are to develop tissue-targeted therapies for cardiometabolic diseases.
Category: GLP-1 News
How to trick the body’s metabolism: Mouse study reveals new path for weight-loss and diabetes treatments – Medical Xpress
How to trick the body’s metabolism: Mouse study reveals new path for weight-loss and diabetes treatments Medical…
Weight loss stalled? Scientists may have figured out a way to trick metabolism into speeding up – New York Post
Weight loss stalled? Scientists may have figured out a way to trick metabolism into speeding up New…
Tackling nutrient deficiencies is key to long-term weight loss success, says nutrition expert – Nutraceutical Business Review
Tackling nutrient deficiencies is key to long-term weight loss success, says nutrition expert Nutraceutical Business Review
Faced with compounded drugs, Eli Lilly tells consumers to ‘be a healthy skeptic’ – Campaign in Canada
Faced with compounded drugs, Eli Lilly tells consumers to ‘be a healthy skeptic’ Campaign in Canada
EC approves Bavarian Nordic’s chikungunya vaccine marketing
The EC has authorised the marketing of Bavarian Nordic's Vimkunya chikungunya vaccine for individuals as young…
Ryoncil, the first FDA-approved mesenchymal stromal cell therapy
Regenerative medicine, a rapidly advancing field, can be generally defined as a therapeutic methodology for the…
AbbVie enters obesity space with $2.3bn Gubra deal
AbbVie is entering the obesity treatment market with a $2.3bn licensing agreement to acquire rights to…
Unexpected Benefit: Popular Weight Loss Drug Ozempic Could Also Help You Drink Less – SciTechDaily
Unexpected Benefit: Popular Weight Loss Drug Ozempic Could Also Help You Drink Less SciTechDaily
As diabetes drives up Kentuckians’ use of weight-loss drugs, worries arise about unintended effects – LINK nky
As diabetes drives up Kentuckians’ use of weight-loss drugs, worries arise about unintended effects LINK nky